Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155406 | SCV000205093 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Thr2086Asn in Exon 32 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (24/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs149202379). |
Eurofins Ntd Llc |
RCV000155406 | SCV000229588 | benign | not specified | 2015-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000155406 | SCV000730471 | benign | not specified | 2017-08-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000954226 | SCV001100845 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000954226 | SCV001147673 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | USH2A: PP4, BP4, BS2 |
ARUP Laboratories, |
RCV000954226 | SCV001157508 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001449589 | SCV001652741 | likely benign | Usher syndrome type 2A | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000155406 | SCV001918815 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000954226 | SCV001973993 | likely benign | not provided | no assertion criteria provided | clinical testing |